Detalhe da pesquisa
1.
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
N Engl J Med
; 384(3): 229-237, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113295
2.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med
; 385(15): 1382-1392, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260849
3.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med
; 384(10): 905-914, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356051
4.
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
J Infect Dis
; 228(Suppl 2): S117-S125, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650230
5.
Long COVID After Bamlanivimab Treatment.
J Infect Dis
; 228(Suppl 2): S126-S135, 2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650236
6.
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Ann Intern Med
; 175(2): 234-243, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928698
7.
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
; 75(1): e440-e449, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718468
8.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Gastroenterology
; 158(3): 537-549.e10, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493397
9.
Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis.
J Allergy Clin Immunol
; 145(3): 922-932, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883845
10.
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 325(7): 632-644, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475701
11.
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
JAMA
; 326(1): 46-55, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081073
12.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
J Am Acad Dermatol
; 83(3): 839-846, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344071
13.
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
N Engl J Med
; 373(14): 1318-28, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26422722
14.
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Gastroenterology
; 153(1): 77-86.e6, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390867
15.
Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis.
Br J Dermatol
; 187(4): 599-602, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481678
16.
Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
Value Health
; 20(8): 1174-1179, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28964451
17.
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.
Am J Gastroenterol
; 111(11): 1599-1607, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481309
18.
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases.
Rheumatology (Oxford)
; 55(suppl 2): ii43-ii55, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856660
19.
Clinical meaningfulness of complete skin clearance in psoriasis.
J Am Acad Dermatol
; 75(1): 77-82.e7, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206759
20.
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
Health Qual Life Outcomes
; 14(1): 104, 2016 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424173